The inflammatory response in myocardial infarction - PubMed (original) (raw)
Review
The inflammatory response in myocardial infarction
Nikolaos G Frangogiannis et al. Cardiovasc Res. 2002 Jan.
Abstract
One of the major therapeutic goals of modern cardiology is to design strategies aimed at minimizing myocardial necrosis and optimizing cardiac repair following myocardial infarction. However, a sound understanding of the biology is necessary before a specific intervention is pursued on a therapeutic basis. This review summarizes our current understanding of the cellular and molecular mechanisms regulating the inflammatory response following myocardial ischemia and reperfusion. Myocardial necrosis induces complement activation and free radical generation, triggering a cytokine cascade initiated by Tumor Necrosis Factor (TNF)-alpha release. If reperfusion of the infarcted area is initiated, it is attended by an intense inflammatory reaction. Interleukin (IL)-8 synthesis and C5a activation have a crucial role in recruiting neutrophils in the ischemic and reperfused myocardium. Neutrophil infiltration is regulated through a complex sequence of molecular steps involving the selectins and the integrins, which mediate leukocyte rolling and adhesion to the endothelium. Marginated neutrophils exert potent cytotoxic effects through the release of proteolytic enzymes and the adhesion with Intercellular Adhesion Molecule (ICAM)-1 expressing cardiomyocytes. Despite this potential injury, substantial evidence suggests that reperfusion enhances cardiac repair improving patient survival; this effect may be in part related to the inflammatory response. Monocyte Chemoattractant Protein (MCP)-1 is also markedly upregulated in the infarcted myocardium inducing recruitment of mononuclear cells in the injured areas. Monocyte-derived macrophages and mast cells may produce cytokines and growth factors necessary for fibroblast proliferation and neovascularization, leading to effective repair and scar formation. At this stage expression of inhibitory cytokines such as IL-10 may have a role in suppressing the acute inflammatory response and in regulating extracellular matrix metabolism. Fibroblasts in the healing scar undergo phenotypic changes expressing smooth muscle cell markers. Our previous review in this journal focused almost exclusively on reduction of the inflammatory injury. The current update is prompted by the potential therapeutic opportunity that the open vessel offers. By promoting more effective tissue repair, it may be possible to reduce the deleterious remodeling, that is the leading cause of heart failure and death. Elucidating the complex interactions and regulatory mechanisms responsible for cardiac repair may allow us to design effective inflammation-related interventions for the treatment of myocardial infarction.
Similar articles
- Inflammatory mechanisms in myocardial infarction.
Ren G, Dewald O, Frangogiannis NG. Ren G, et al. Curr Drug Targets Inflamm Allergy. 2003 Sep;2(3):242-56. doi: 10.2174/1568010033484098. Curr Drug Targets Inflamm Allergy. 2003. PMID: 14561159 Review. - The inflammatory response and cardiac repair after myocardial infarction.
Nah DY, Rhee MY. Nah DY, et al. Korean Circ J. 2009 Oct;39(10):393-8. doi: 10.4070/kcj.2009.39.10.393. Epub 2009 Oct 28. Korean Circ J. 2009. PMID: 19949583 Free PMC article. - Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.
Zymek P, Nah DY, Bujak M, Ren G, Koerting A, Leucker T, Huebener P, Taffet G, Entman M, Frangogiannis NG. Zymek P, et al. Cardiovasc Res. 2007 May 1;74(2):313-22. doi: 10.1016/j.cardiores.2006.11.028. Epub 2006 Nov 23. Cardiovasc Res. 2007. PMID: 17188669 Free PMC article. - The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M, Herzog C, Larmann J, Schmitz M, Hilfiker-Kleiner D, Gessner JE, Theilmeier G. Mueller M, et al. Immunobiology. 2013 Sep;218(9):1131-8. doi: 10.1016/j.imbio.2013.03.006. Epub 2013 Mar 28. Immunobiology. 2013. PMID: 23642836 - Targeting the inflammatory response in healing myocardial infarcts.
Frangogiannis NG. Frangogiannis NG. Curr Med Chem. 2006;13(16):1877-93. doi: 10.2174/092986706777585086. Curr Med Chem. 2006. PMID: 16842199 Review.
Cited by
- Insulin resistance and inflammation markers in myocardial infarction.
Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O. Gruzdeva O, et al. J Inflamm Res. 2013 Jun 17;6:83-90. doi: 10.2147/JIR.S43081. Print 2013. J Inflamm Res. 2013. PMID: 23837002 Free PMC article. - p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts.
Sinfield JK, Das A, O'Regan DJ, Ball SG, Porter KE, Turner NA. Sinfield JK, et al. Biochem Biophys Res Commun. 2013 Jan 4;430(1):419-24. doi: 10.1016/j.bbrc.2012.11.071. Epub 2012 Dec 1. Biochem Biophys Res Commun. 2013. PMID: 23206705 Free PMC article. - Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction.
Nishikido T, Oyama J, Shiraki A, Komoda H, Node K. Nishikido T, et al. J Am Heart Assoc. 2016 Apr 4;5(4):e002863. doi: 10.1161/JAHA.115.002863. J Am Heart Assoc. 2016. PMID: 27045005 Free PMC article. - Molecular and cellular mechanisms of cigarette smoke-induced myocardial injury: prevention by vitamin C.
Das A, Dey N, Ghosh A, Das S, Chattopadhyay DJ, Chatterjee IB. Das A, et al. PLoS One. 2012;7(9):e44151. doi: 10.1371/journal.pone.0044151. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970172 Free PMC article. - Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations.
Kayser S, Brunner P, Althaus K, Dorst J, Sheriff A. Kayser S, et al. J Clin Med. 2020 Sep 12;9(9):2947. doi: 10.3390/jcm9092947. J Clin Med. 2020. PMID: 32932587 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous